149 related articles for article (PubMed ID: 32127947)
1. Lnc-SNHG16/miR-128 axis modulates malignant phenotype through WNT/β-catenin pathway in cervical cancer cells.
Wu W; Guo L; Liang Z; Liu Y; Yao Z
J Cancer; 2020; 11(8):2201-2212. PubMed ID: 32127947
[No Abstract] [Full Text] [Related]
2. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
[TBL] [Abstract][Full Text] [Related]
3. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
[No Abstract] [Full Text] [Related]
4. The encouraging role of long noncoding RNA small nuclear RNA host gene 16 in epithelial-mesenchymal transition of bladder cancer via directly acting on miR-17-5p/metalloproteinases 3 axis.
Peng H; Li H
Mol Carcinog; 2019 Aug; 58(8):1465-1480. PubMed ID: 31026378
[TBL] [Abstract][Full Text] [Related]
5. miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/β-catenin signaling.
Ji X; Guo H; Yin S; Du H
Onco Targets Ther; 2019; 12():7739-7748. PubMed ID: 31571923
[TBL] [Abstract][Full Text] [Related]
6. MiR-145 inhibits cervical cancer progression and metastasis by targeting WNT2B by Wnt/β-catenin pathway.
Li Q; Yu X; Yang L
Int J Clin Exp Pathol; 2019; 12(10):3740-3751. PubMed ID: 31933762
[TBL] [Abstract][Full Text] [Related]
7. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
8. In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells.
Zhang Z; Li F; Li Y; Li Z; Jia G
Clin Breast Cancer; 2023 Apr; 23(3):302-316. PubMed ID: 36639265
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression.
Chen H; Li M; Huang P
J Cancer; 2019; 10(15):3571-3581. PubMed ID: 31293662
[TBL] [Abstract][Full Text] [Related]
10. MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.
Bai D; Sun H; Wang X; Lou H; Zhang J; Wang X; Jiang L
Med Sci Monit; 2017 Oct; 23():4885-4894. PubMed ID: 29023429
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma.
Lu YF; Cai XL; Li ZZ; Lv J; Xiang YA; Chen JJ; Chen WJ; Sun WY; Liu XM; Chen JB
Cell Physiol Biochem; 2018; 45(5):1975-1985. PubMed ID: 29529599
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG16 promotes lipopolysaccharides-induced acute pneumonia in A549 cells via targeting miR-370-3p/IGF2 axis.
Zhang J; Mao F; Zhao G; Wang H; Yan X; Zhang Q
Int Immunopharmacol; 2020 Jan; 78():106065. PubMed ID: 31841752
[TBL] [Abstract][Full Text] [Related]
13. SNHG16/miR-140-5p axis promotes esophagus cancer cell proliferation, migration and EMT formation through regulating ZEB1.
Zhang K; Chen J; Song H; Chen LB
Oncotarget; 2018 Jan; 9(1):1028-1040. PubMed ID: 29416674
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
16. SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression.
Liu Y; Gu S; Li H; Wang J; Wei C; Liu Q
Biochem Biophys Res Commun; 2019 Oct; 518(1):127-133. PubMed ID: 31427084
[TBL] [Abstract][Full Text] [Related]
17. SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells.
Zhu H; Zeng Y; Zhou CC; Ye W
Arch Biochem Biophys; 2018 Jan; 637():1-8. PubMed ID: 29126969
[TBL] [Abstract][Full Text] [Related]
18. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
Zeng M; Zhu L; Li L; Kang C
Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
[TBL] [Abstract][Full Text] [Related]
19. MiR-638 inhibits cervical cancer metastasis through Wnt/β-catenin signaling pathway and correlates with prognosis of cervical cancer patients.
Wei H; Zhang JJ; Tang QL
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5587-5593. PubMed ID: 29271990
[TBL] [Abstract][Full Text] [Related]
20. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
